Q2 2018 Holdings
Filed 2018-08-10 | 261 holdings | $9.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $645.0K | 7,652 | 6.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $693.0K | 2,388 | 7.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $705.0K | 4,587 | 7.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $713.0K | 85,880 | 7.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $723.0K | 72,408 | 7.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $739.0K | 32,334 | 8.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $747.0K | 7,581 | 8.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $764.0K | 8,114 | 8.2% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $774.0K | 65,221 | 8.3% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $820.0K | 143,132 | 8.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $933.0K | 68,587 | 10.0% |